Tuesday 05 November 2024
italiano
Assobiotec
About us
Governance
Working groups
Our members
Staff
International Events
BioInItaly Investment Forum
Biotech Week
International Forum on Industrial Biotechnology and Bioeconomy (IFIB)
Biotech industry
Press Room
Assobiotec
About us
Governance
Working groups
Our members
Staff
International Events
BioInItaly Investment Forum
Biotech Week
International Forum on Industrial Biotechnology and Bioeconomy (IFIB)
Biotech industry
Press Room
Home
/
News
News
Share
Print
Coronavirus
24 November 2020
Reithera announces its GRAd-COV2 COVID-19 vaccine candidate is well tolerated and induces clear immune responses in healthy subject aged 18-55 years phase 1 trial to advance into elderly subjects aged 65-85 years
ReiThera provides an update on the ongoing Phase 1 study of its vaccine candidate (GRAd-COV2) against the novel coronavirus (SARS-CoV-2)
Read more
Coronavirus
01 May 2020
CORONAVIRUS - Axxam supports drug discovery efforts to identify novel inhibitors for SARS-CoV-2
A commitment to support the identification of antiviral therapies to treat the severe acute respiratory syndrome COVID-19, caused by the Coronavirus SARS-CoV-2.
Read more
Coronavirus
23 March 2020
CORONAVIRUS - DiaSorin COVID-19 test has received FDA Emergency Use Authorization
DiaSorin Molecular LLC, a division of DiaSorin S.p.A. announced that it has received Emergency Use Authorization (EUA) from the FDA for their Simplexa™ COVID-19 Direct kit.
Read more
Coronavirus
21 March 2020
CORONAVIRUS - Takis announces that it is ready to test its Covid-19 vaccine on pre-clinical models
The authorization comes from the Ministry of Health and represents the first step in bringing the vaccine to human use. Takis researchers are the only ones in Italy and the first in Europe to access this phase of the experimentation.
Read more
Coronavirus
10 March 2020
CORONAVIRUS - DiaSorin has completed the studies to support the launch by the end of march 2020 of a rapid response molecular diagnostic test for the COVID-19
DiaSorin announced that it has completed at the Spallanzani Hospital in Rome and at the Policlinico San Matteo in Pavia, the studies necessary to support the CE marking and FDA EUA submission of an innovative molecular test for the rapid identification of the novel coronavirus COVID-19.
Read more
Coronavirus
03 March 2020
CORONAVIRUS - Applied DNA Sciences updates on COVID-19 collaboration with Takis Biotech, 4 Preclinical LinearDNA™ Vaccine candidates designed
Applied DNA Sciences Inc. and Takis Biotech announced that the design of 4 DNA vaccine candidates that will be produced for preclinical animal testing via the Company’s proprietary PCR-based DNA manufacturing systems
Read more
Coronavirus
1
2
Where to find us
20149 Milan
Via Giovanni da Procida, 11
Show map
Tel.
+39 02.34565.1
Fax. +39 02.34565.310
Segreteria Assobiotec
Tel. 02 34565.256/341
assobiotec@federchimica.it